NEW YORK (Reuters Health) – The combination of an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB) is often prescribed for elderly patients who do not…
WASHINGTON (from The George Washington University) – A new study by The George Washington University School of Medicine and Health Sciences, that will be published in the Journal…
Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stress and anxiety. Depression and anxiety are directly linked to HPA (hypothalamic-pituitary-adrenal axis) and increase in cortisol. SSRIs…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…
NEW YORK (Reuters Health) – A review published by the Cochrane Library concludes that artesunate should replace quinine as the standard treatment for severe malaria. Dr. David Sinclair,…
NEW YORK (Reuters Health) – Current evidence is still inconclusive as to whether patients with chronic kidney disease (CKD) may benefit from aggressive blood pressure control, according to…
NEW YORK (Reuters Health) – A single dose of zoledronate prevents bone loss associated with glucocorticoid therapy given for acute exacerbation of Crohn’s disease, a German team reports…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
NEW YORK (Reuters Health) — Elderly women who were treated for urinary tract infections with trimethoprim-sulfamethoxazole were 3 times more likely to be hospitalized for hyperkalemia in the…
Mark R. Chassin, MD, President of the Joint Commission, discusses flu vaccination in the workplace. When healthcare workers are vaccinated at high rates, transmission in hospitals is reduced,…